CASI Pharmaceuticals, Inc. ( CASIF) - Key Metrics
CASIF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.24 | -$0.49 | $0 | $0 |
| 2026Q1 | $0.24 | -$0.49 | $0 | $0 |
| 2025Q4 | $0.35 | -$0.63 | $0 | $0 |
| 2025Q3 | $0.19 | -$0.68 | $0 | $0 |
| 2025Q2 | $0.27 | -$0.86 | $0 | $0 |
CASIF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.09 |
| 2026Q1 | 0% | -0.06 |
| 2025Q4 | 0% | -0.34 |
| 2025Q3 | 0% | -0.61 |
| 2025Q2 | 0% | -0.34 |
CASIF
Price: $0.10
52 week price:
Earnings Per Share: -3.02 USD
P/E Ratio: -0.05
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.5 million